0.00Open0.00Pre Close0 Volume0 Open Interest0.50Strike Price0.00Turnover0.00%IV58.16%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.68Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Reviva Pharmaceuticals Stock Discussion
$3.50 - $4?
don't mind if I do.
$Ambrx Biopharma(AMAM.US)$
The biotech sector faced challenges in the previous year, mainly attributed to high inflation and interest rates, particularly impacting small-cap biotech firms in the difficult fundraising environment of summer 2023.
As a consequence, numerous companies experienced a significant drop in their market caps, with some even falling below the 100 million mark, a rarity...
Dow Jones· 1 min ago
No comment yet